{"id":"https://openalex.org/W4362481007","doi":"https://doi.org/10.1158/2159-8290.22532840.v1","title":"Table S1 from Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers","display_name":"Table S1 from Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362481007","doi":"https://doi.org/10.1158/2159-8290.22532840.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.22532840.v1","doi":"https://doi.org/10.1158/2159-8290.22532840.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22532840.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2159-8290.22532840.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042569929","display_name":"Laetitia Seguin","orcid":"https://orcid.org/0000-0002-9610-7093","observed_orcids":["https://orcid.org/0000-0002-9610-7093","https://orcid.org/0000-0003-2950-4766"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laetitia Seguin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102723395","display_name":"Maria F. Camargo","orcid":"https://orcid.org/0000-0003-3405-8430","observed_orcids":["https://orcid.org/0000-0003-3405-8430"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria F. Camargo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079170443","display_name":"Hiromi Inoue Wettersten","orcid":"https://orcid.org/0000-0001-7144-3122","observed_orcids":["https://orcid.org/0000-0001-7144-3122"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiromi I. Wettersten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086626483","display_name":"Shumei Kato","orcid":"https://orcid.org/0000-0003-1193-1815","observed_orcids":["https://orcid.org/0000-0003-1193-1815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shumei Kato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048259311","display_name":"Jay S. Desgrosellier","orcid":"https://orcid.org/0000-0001-8097-0143","observed_orcids":["https://orcid.org/0000-0001-8097-0143"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jay S. Desgrosellier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036182229","display_name":"Tami Von Schalscha","orcid":"https://orcid.org/0009-0007-8348-6200","observed_orcids":["https://orcid.org/0009-0007-8348-6200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tami von Schalscha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044524575","display_name":"Kathryn C. Elliott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathryn C. Elliott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023172789","display_name":"Erika C. Cosset","orcid":"https://orcid.org/0000-0001-5481-6556","observed_orcids":["https://orcid.org/0000-0001-5481-6556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika Cosset","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031703863","display_name":"Jacqueline Lesperance","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacqueline Lesperance","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030557212","display_name":"Sara M. Weis","orcid":"https://orcid.org/0009-0008-3137-4239","observed_orcids":["https://orcid.org/0009-0008-3137-4239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara M. Weis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089796560","display_name":"David A. Cheresh","orcid":"https://orcid.org/0000-0002-7193-8595","observed_orcids":["https://orcid.org/0000-0002-7193-8595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Cheresh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13426","display_name":"Kruppel-like factors research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galectin-3","display_name":"galectin-3","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cell-lines","display_name":"cell lines","score":0.6510000228881836},{"id":"https://openalex.org/keywords/drug-vulnerability","display_name":"drug vulnerability","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.8703176975250244},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6795623898506165},{"id":"https://openalex.org/C95713431","wikidata":"https://www.wikidata.org/wiki/Q631425","display_name":"Vulnerability (computing)","level":2,"score":0.623613715171814},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.5518758893013},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48801389336586},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4000299870967865},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3918358385562897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3860875964164734},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.361911416053772},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3181178569793701},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23940110206604004},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.21557921171188354},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.17349061369895935},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.08940300345420837},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.07334011793136597},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06105303764343262},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2159-8290.22532840.v1","doi":"https://doi.org/10.1158/2159-8290.22532840.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22532840.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22532840","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Table_S1_from_Galectin-3_a_Druggable_Vulnerability_for_KRAS-Addicted_Cancers/22532840","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.22532840.v1","doi":"https://doi.org/10.1158/2159-8290.22532840.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22532840.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362481025","https://openalex.org/W4362481190","https://openalex.org/W4362481165","https://openalex.org/W4362481175","https://openalex.org/W4362481016","https://openalex.org/W2755492550","https://openalex.org/W2741924326","https://openalex.org/W4255055697","https://openalex.org/W7046814002","https://openalex.org/W7136753060"],"abstract_inverted_index":{"Characteristics":[0],"of":[1],"cell":[2],"lines":[3]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-04-05T00:00:00"}